Insider Transactions Reported by 7 Insiders of
MAINZ BIOMED N.V.
-
Symbol
-
MYNZ on Nasdaq
-
Location
-
Mainz, Germany
Quick Takeaways
- MYNZ - MAINZ BIOMED N.V. has 7 insiders with reported activity on this page.
- Net insider value flow over the last year: +$1,034,350.
- Recent transaction rows are available for direct filing-level review.
What Changed
- Buy value: $1,034,350; sell value: $0.
- Net share flow: <span class="text-green-600">+685,000</span>.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Official SEC Source
Filed on Form 4
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
See Original Filing
Insiders trading volume in the past year
Insider trading buckets (0-12 months)
MAINZ BIOMED N.V. executives and other stock owners filed with the SEC include:
| Name |
Relationship |
Holdings Value |
Past Year Net Change |
Change % |
Valuation |
Report Date |
| Kevin Michael Donahue |
10%+ Owner |
$1,034,350 |
+$1,034,350 |
+100% |
Filing P/S |
17 Oct 2025 |
| Guido Baechler |
Chief Executive Officer, Director |
$738,170 |
|
|
Mixed |
13 Feb 2026 |
| William J. Caragol |
Chief Financial Officer |
$448,836 |
|
|
Mixed |
13 Feb 2026 |
| Heinrich Dreismann |
Director |
$78,934 |
|
|
Mixed |
13 Feb 2026 |
| Gregory J. Tibbitts |
Director |
$68,167 |
|
|
Mixed |
13 Feb 2026 |
| Hans Hekland |
Director |
$54,900 |
|
|
Mixed |
01 Jan 2026 |
| David E. Lazar |
Director |
$0 |
|
|
Mixed |
13 Feb 2026 |
Recent Insider Transactions by Companies or Individuals for MAINZ BIOMED N.V.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider |
Symbol |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares Owned |
Date |
Ownership |
| David E. Lazar |
MYNZ |
Series C Preferred Shares |
Award |
|
|
|
1,000,000 |
1,000,000 |
13 Feb 2026 |
Direct |
| David E. Lazar |
MYNZ |
Series B Preferred Shares |
Award |
|
|
|
1,000,000 |
1,000,000 |
13 Feb 2026 |
Direct |
| David E. Lazar |
MYNZ |
Series A Preferred Shares |
Award |
|
|
|
1,000,000 |
1,000,000 |
13 Feb 2026 |
Direct |
| William J. Caragol |
MYNZ |
Ordinary Shares |
Award |
372.3% |
|
|
290,000 |
367,899 |
13 Feb 2026 |
Direct |
| Heinrich Dreismann |
MYNZ |
Ordinary Shares |
Award |
228.4% |
|
|
45,000 |
64,700 |
13 Feb 2026 |
Direct |
| Gregory J. Tibbitts |
MYNZ |
Ordinary Shares |
Award |
413.8% |
|
|
45,000 |
55,875 |
13 Feb 2026 |
Direct |
| Guido Baechler |
MYNZ |
Ordinary Shares |
Award |
266.6% |
|
|
440,000 |
605,058 |
13 Feb 2026 |
Direct |
| Kevin Michael Donahue |
MYNZ |
Common Stock |
Purchase |
|
$1,034,350 |
$1.51 |
685,000 |
685,000 |
17 Oct 2025 |
Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.